These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

205 related items for PubMed ID: 25444135

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Preclinical assessments of vaginal microbicide candidate safety and efficacy.
    Fernández-Romero JA, Teleshova N, Zydowsky TM, Robbiani M.
    Adv Drug Deliv Rev; 2015 Sep 15; 92():27-38. PubMed ID: 25543007
    [Abstract] [Full Text] [Related]

  • 3. Clinical development of microbicides for the prevention of HIV infection.
    D'Cruz OJ, Uckun FM.
    Curr Pharm Des; 2004 Sep 15; 10(3):315-36. PubMed ID: 14754390
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Prioritizing prevention of HIV and sexually transmitted infections: first-generation vaginal microbicides.
    Madan RP, Keller MJ, Herold BC.
    Curr Opin Infect Dis; 2006 Feb 15; 19(1):49-54. PubMed ID: 16374218
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Microbicide drug candidates to prevent HIV infection.
    Balzarini J, Van Damme L.
    Lancet; 2007 Mar 03; 369(9563):787-797. PubMed ID: 17336656
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Microbicides for the prevention of sexually transmitted HIV infection.
    Karim QA, Baxter C.
    Expert Rev Anti Infect Ther; 2013 Jan 03; 11(1):13-23. PubMed ID: 23428099
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Microbicides to prevent HIV transmission: overcoming obstacles to chemical barrier protection.
    Dhawan D, Mayer KH.
    J Infect Dis; 2006 Jan 01; 193(1):36-44. PubMed ID: 16323129
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Historical development of vaginal microbicides to prevent sexual transmission of HIV in women: from past failures to future hopes.
    Notario-Pérez F, Ruiz-Caro R, Veiga-Ochoa MD.
    Drug Des Devel Ther; 2017 Jan 01; 11():1767-1787. PubMed ID: 28670111
    [Abstract] [Full Text] [Related]

  • 15. Promising microbicide approach for prevention of human immunodeficiency virus transmission needs more support.
    Idemyor V.
    Pharmacotherapy; 2002 Aug 01; 22(8):1074-6. PubMed ID: 12173795
    [Abstract] [Full Text] [Related]

  • 16. Microbicides for preventing transmission of genital herpes.
    Zeitlin L, Whaley KJ.
    Herpes; 2002 Apr 01; 9(1):4-9. PubMed ID: 11916493
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Microbicides: a new frontier in HIV prevention.
    McGowan I.
    Biologicals; 2006 Dec 01; 34(4):241-55. PubMed ID: 17097303
    [Abstract] [Full Text] [Related]

  • 19. Is HIV drug resistance a limiting factor in the development of anti-HIV NNRTI and NRTI-based vaginal microbicide strategies?
    Martinez J, Coplan P, Wainberg MA.
    Antiviral Res; 2006 Sep 01; 71(2-3):343-50. PubMed ID: 16787667
    [Abstract] [Full Text] [Related]

  • 20. Tests of Buffergel for contraception and prevention of sexually transmitted diseases in animal models.
    Zeitlin L, Hoen TE, Achilles SL, Hegarty TA, Jerse AE, Kreider JW, Olmsted SS, Whaley KJ, Cone RA, Moench TR.
    Sex Transm Dis; 2001 Jul 01; 28(7):417-23. PubMed ID: 11460027
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.